Trials / Withdrawn
WithdrawnNCT01313702
Single Pill to Avert Cardiovascular Events
Effect of Polipill on Patients at High Cardiovascular Risk : a Randomized Controlled Trial
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Hospital do Coracao · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether a polipill improved the compliance with treatment compared to usual care that use two or more drugs,in patients at high cardiovascular risk or previous cardiovascular disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | polipillV1 | polipill version 1: aspirin 75mg, simvastatin 40mg, lisinopril 10mg, atenolol 50mg |
| DRUG | polipillV2 | Polipill version 2: aspirin 75mg, simvastatin 40mg, lisinopril 10mg, hydrochlorothiazide 12.5mg. |
| DRUG | usual care | the drugs used in clinical practice, defined by physician |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-04-01
- Completion
- 2014-07-01
- First posted
- 2011-03-14
- Last updated
- 2022-09-21
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01313702. Inclusion in this directory is not an endorsement.